Le Lézard
Classified in: Health, Science and technology
Subjects: CALENDAR OF EVENTS, TRADE SHOWS/SEMINARS/WEBINARS, MISCELLANEOUS

Assure Holdings to Present at the 2018 World Outlook Financial Conference


PARKER, Colo., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (TSX-V:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, will be participating in the 2018 World Outlook Financial Conference in Vancouver, BC on Friday, February 2nd and Saturday, February 3rd at the Westin Bayshore Hotel.

Assure will conduct 1-on-1 and group meetings throughout the two-day event and will be a keynote speaker during the VIP lunch held on Saturday February 3rd. This sold out conference is attended by both retail and institutional investors that have a focus on early stage public companies.

A webcast of the event will be archived after the event on the Company's website at www.AssureIOM.com.

About Assure Holdings

Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. While Assure focuses primarily on supporting spinal and vascular surgeries, plans are in place to support other classes of medicine that rely on the standard of care that intraoperative neuromonitoring provides. For more information, visit the company's website at assureIOM.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts

Matthew Willer, President
Assure Holdings
(720) 287-3093
[email protected]

Cody Slach, Managing Director
Liolios Investor Relations
(949) 574-3860
[email protected]


These press releases may also interest you

at 17:26
Amgen today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE® (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American...

at 17:05
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Toronto Stock Exchange ("TSX") is reviewing the eligibility for continued listing on the TSX of the securities of the Company. The TSX has identified the Company's financial...

at 16:30
Viatris Inc.  will report its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and other Company executives will host a webcast at 8:30 a.m. ET on the...

at 16:30
WELL Health Clinic Network Inc. ("WELL"), a subsidiary of WELL Health Technologies Corp. , a digital healthcare company focused on...

at 16:25
Precision BioSciences, Inc. , an advanced gene editing company, today announced the anticipated return of three programs from Prevail Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company. Precision exercised its option to regain...

at 16:25
AIDS Healthcare Foundation (AHF), the world's largest HIV/AIDS organization, is calling on public health officials to provide more education and prevention services around vaccinations as a new measles outbreak spreads through 17 U.S. states. As of...



News published on and distributed by: